Abstract
Little is known about the side effects of micafungin in extremely low birth weight infants. In a retrospective single-center study, 19 extremely low birth weight infants were analyzed for micafungin efficacy and safety. At a mean±standard deviation daily dosage of 7.5 ± 2.0 mg/kg, no clinically relevant side effects were observed. A significant increase of liver enzymes was reversible after treatment.
| Original language | English |
|---|---|
| Pages (from-to) | e169-e172 |
| Journal | The Pediatric Infectious Disease Journal |
| Volume | 37 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Jun 2018 |
| Externally published | Yes |